Literature DB >> 31448924

Effect of Particle Formation Process on Characteristics and Aerosol Performance of Respirable Protein Powders.

Ashlee D Brunaugh1, Tian Wu2, Sekhar R Kanapuram2, Hugh D C Smyth1.   

Abstract

Pulmonary delivery of biopharmaceuticals may enable targeted local therapeutic effect and noninvasive systemic administration. Dry powder inhaler (DPI) delivery is an established patient-friendly approach for delivering large molecules to the lungs; however, the complexities of balancing protein stability with aerosol performance require that the design space of biopharmaceutical DPI formulations is rigorously explored. Utilizing four rationally selected formulations obtained using identical atomization conditions, an extensive study of the effect of the particle formation process (spray drying or spray freeze-drying) on powder properties, aerosol performance, and protein stability was performed. Multiple linear regression analysis was used to understand the relationship between powder properties, device dispersion mechanism, and aerosol performance. Spray drying and spray freeze-drying, despite the same spraying conditions, produced powders with vastly different physical characteristics, though similar aerosol performance. The resulting regression model points to the significance of particle size, density, and surface properties on the resulting aerosol performance, with these factors weighing differently according to the device dispersion mechanism utilized (shear-based or impaction-based). The physical properties of the produced spray dried and spray freeze-dried powders have differing implications for long-term stability, which will be explored extensively in a future study.

Entities:  

Keywords:  biopharmaceutical; dispersibility; particle engineering; pulmonary drug delivery; spray drying; spray freeze-drying

Mesh:

Substances:

Year:  2019        PMID: 31448924      PMCID: PMC6800019          DOI: 10.1021/acs.molpharmaceut.9b00496

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  54 in total

1.  Protein inhalation powders: spray drying vs spray freeze drying.

Authors:  Y F Maa; P A Nguyen; T Sweeney; S J Shire; C C Hsu
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

Review 2.  Dry powder inhaler formulation.

Authors:  Martin J Telko; Anthony J Hickey
Journal:  Respir Care       Date:  2005-09       Impact factor: 2.258

3.  True density analysis of a freeze-dried amorphous sugar matrix.

Authors:  Koreyoshi Imamura; Yoshinobu Maruyama; Kazuhiro Tanaka; Tohru Yokoyama; Hiroyuki Imanaka; Kazuhiro Nakanishi
Journal:  J Pharm Sci       Date:  2008-07       Impact factor: 3.534

Review 4.  The freezing step in lyophilization: physico-chemical fundamentals, freezing methods and consequences on process performance and quality attributes of biopharmaceuticals.

Authors:  Julia Christina Kasper; Wolfgang Friess
Journal:  Eur J Pharm Biopharm       Date:  2011-03-21       Impact factor: 5.571

5.  Surface-induced denaturation of proteins during freezing and its inhibition by surfactants.

Authors:  B S Chang; B S Kendrick; J F Carpenter
Journal:  J Pharm Sci       Date:  1996-12       Impact factor: 3.534

Review 6.  Role of Buffers in Protein Formulations.

Authors:  Teddy J Zbacnik; Ryan E Holcomb; Derrick S Katayama; Brian M Murphy; Robert W Payne; Richard C Coccaro; Gabriel J Evans; James E Matsuura; Charles S Henry; Mark Cornell Manning
Journal:  J Pharm Sci       Date:  2016-11-26       Impact factor: 3.534

Review 7.  Spray drying of pharmaceuticals and biopharmaceuticals: Critical parameters and experimental process optimization approaches.

Authors:  Ahmad Ziaee; Ahmad B Albadarin; Luis Padrela; Tim Femmer; Emmet O'Reilly; Gavin Walker
Journal:  Eur J Pharm Sci       Date:  2018-11-11       Impact factor: 4.384

8.  Decreased protein-stabilizing effects of cryoprotectants due to crystallization.

Authors:  K Izutsu; S Yoshioka; T Terao
Journal:  Pharm Res       Date:  1993-08       Impact factor: 4.200

9.  Spray-drying of air-liquid interface sensitive recombinant human growth hormone.

Authors:  Y F Maa; P A Nguyen; S W Hsu
Journal:  J Pharm Sci       Date:  1998-02       Impact factor: 3.534

10.  Physical characterization of component particles included in dry powder inhalers. II. Dynamic characteristics.

Authors:  Anthony J Hickey; Heidi M Mansour; Martin J Telko; Zhen Xu; Hugh D C Smyth; Tako Mulder; Richard McLean; John Langridge; Dimitris Papadopoulos
Journal:  J Pharm Sci       Date:  2007-05       Impact factor: 3.534

View more
  3 in total

1.  Carrier Effect in Development of Rifampin Loaded Proliposome for Pulmonary Delivery: A Quality by Design Study.

Authors:  Elahehnaz Parhizkar; Delaram Sadeghinia; Hamed Hamishehkar; Shadi Yaqoubi; Ali Nokhodchi; Shohreh Alipour
Journal:  Adv Pharm Bull       Date:  2021-05-18

2.  Advancements in Particle Engineering for Inhalation Delivery of Small Molecules and Biotherapeutics.

Authors:  Rachel Yoon Kyung Chang; Hak-Kim Chan
Journal:  Pharm Res       Date:  2022-09-07       Impact factor: 4.580

3.  Development of an Innovative, Carrier-Based Dry Powder Inhalation Formulation Containing Spray-Dried Meloxicam Potassium to Improve the In Vitro and In Silico Aerodynamic Properties.

Authors:  Edit Benke; Árpád Farkas; Piroska Szabó-Révész; Rita Ambrus
Journal:  Pharmaceutics       Date:  2020-06-10       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.